[Summarize drug dosage forms in treatment of age-related macular degeneration disease]

Mao-Bo Du; Shu-Zhi Liu; Kai Xu; Li-Na Liang; Ai-Ping He; Yao Yao; Ya-Mei Liu

doi:10.19540/j.cnki.cjcmm.20170121.007

[Summarize drug dosage forms in treatment of age-related macular degeneration disease]

Zhongguo Zhong Yao Za Zhi. 2017 Feb;42(4):628-633. doi: 10.19540/j.cnki.cjcmm.20170121.007.

[Article in Chinese]

Authors

Mao-Bo Du¹, Shu-Zhi Liu¹, Kai Xu², Li-Na Liang², Ai-Ping He¹, Yao Yao¹, Ya-Mei Liu¹

Affiliations

¹ Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
² Eye Hospital, China Academy of Chinese Medical Sciences, Beijing 100040, China.

PMID: 28959828
DOI: 10.19540/j.cnki.cjcmm.20170121.007

Abstract

In this review, the authors summarized the drugs in treatment of the age-related macular degeneration (AMD or ARMD), including the pathogenesis of the age-related macular degeneration at home and abroad, dosage forms used in the treatment, and the drugs research and development directions in the future. AMD disease is the third largest blinding diseases all over the world, with an incidence of 6.62%. The dosage form of the traditional medicine is mostly oral formulations, playing a role in body, while the newly dosage form is topical drug delivery formulation. Traditional Chinese medicine (TCM) has certain advantages in the treatment of AMD disease and the development of topical drug delivery preparations with newly preparation technologies would have a very bright prospect in the future.

Keywords: age-related macular degeneration(AMD); drug dosage forms; ophthalmology; traditional Chinese medicine(TCM).

Publication types

Review

MeSH terms

Administration, Ophthalmic
Administration, Oral
Drug Delivery Systems
Humans
Macular Degeneration / drug therapy*
Medicine, Chinese Traditional